Arcturus Therapeutics Holdings (ARCT) Receivables - Net: 2018-2025
Historic Receivables - Net for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $8.0 million.
- Arcturus Therapeutics Holdings' Receivables - Net fell 73.67% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 73.67%. This contributed to the annual value of $4.0 million for FY2024, which is 87.61% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Receivables - Net is $8.0 million, which was down 53.78% from $17.2 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Receivables - Net high stood at $92.5 million for Q1 2023, and its period low was $2.0 million during Q1 2021.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Receivables - Net value was $24.1 million (recorded in 2024), while the average stood at $26.4 million.
- In the last 5 years, Arcturus Therapeutics Holdings' Receivables - Net surged by 2,405.64% in 2023 and then plummeted by 87.61% in 2024.
- Over the past 5 years, Arcturus Therapeutics Holdings' Receivables - Net (Quarterly) stood at $3.4 million in 2021, then fell by 17.91% to $2.8 million in 2022, then soared by 1,060.06% to $32.1 million in 2023, then crashed by 87.61% to $4.0 million in 2024, then slumped by 73.67% to $8.0 million in 2025.
- Its Receivables - Net was $8.0 million in Q3 2025, compared to $17.2 million in Q2 2025 and $14.6 million in Q1 2025.